Viatris (VTRS) Non-Current Debt (2019 - 2026)
Viatris (VTRS) posted quarterly Non-Current Debt of $12.4 billion for Q1 2026, down 12.44% year-over-year from $14.2 billion in Q1 2025, and down 0.54% quarter-over-quarter from $12.5 billion in Q4 2025.
Viatris (VTRS) Non-Current Debt (2019 - 2026) Analysis & Trends
Viatris' Non-Current Debt history runs 8 years deep, the most recent figure standing at $12.4 billion for Q1 2026.
- In Q1 2026, Non-Current Debt fell 12.44% year-over-year to $12.4 billion; the TTM figure through Mar 2026 stood at $12.4 billion (down 12.44% YoY), while the FY2025 annual figure was $12.5 billion, down 11.1% from the prior year.
- Non-Current Debt for Q1 2026 stood at $12.4 billion, down from $12.5 billion in the prior quarter.
- The five-year high for Non-Current Debt was $19.2 billion in Q2 2022, with the low at $12.4 billion in Q1 2026.
- The 5-year median for Non-Current Debt is $16.1 billion (2024), against an average of $15.7 billion.
- The sharpest annual moves came in 2023 and 2024: Non-Current Debt slipped 3.69% in 2023, then declined 16.24% in 2024.
- Viatris' Non-Current Debt stood at $18.0 billion in 2022, then declined by 10.14% to $16.2 billion in 2023, then slipped by 13.28% to $14.0 billion in 2024, then dropped by 11.1% to $12.5 billion in 2025, then retreated by 0.54% to $12.4 billion in 2026.
- Business Quant data shows VTRS's Non-Current Debt at $12.4 billion in Q1 2026, $12.5 billion in Q4 2025, and $12.5 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | -8.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 12.09 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 27.73 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 11.61 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 3.85 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 130.00 Mn |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 1.48 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.61 Bn |
| Mar 31, 2026 | 12.41 Bn |
| Dec 31, 2025 | 12.48 Bn |
| Sep 30, 2025 | 12.49 Bn |
| Jun 30, 2025 | 12.79 Bn |
| Mar 31, 2025 | 14.18 Bn |
| Dec 31, 2024 | 14.04 Bn |
| Sep 30, 2024 | 14.30 Bn |
| Jun 30, 2024 | 14.73 Bn |
| Mar 31, 2024 | 16.07 Bn |
| Dec 31, 2023 | 16.19 Bn |
| Sep 30, 2023 | 17.08 Bn |
| Jun 30, 2023 | 17.25 Bn |
| Mar 31, 2023 | 18.07 Bn |
| Dec 31, 2022 | 18.02 Bn |
| Sep 30, 2022 | 18.72 Bn |
| Jun 30, 2022 | 19.21 Bn |
| Mar 31, 2022 | 18.76 Bn |
| Dec 31, 2021 | 19.72 Bn |
| Sep 30, 2021 | 19.85 Bn |